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Triamterene-H is a drug commonly  
used to treat hypertension. Its side effects 
include thrombocytopenia, aplastic anemia, 
agranulocytosis, leukopenia, and 
megaloblastic anemia due to low 
concentration of folic acid. Thrombocytopenia 
due to drug adverse event is not diagnosed 
most often and patients with other 
differential diagnosis are subjected to 
invasive medical practice including bone 
marrow aspiration. Therefore, attention to 
the patient’s drugs in order to rule out drugs 
inducing thrombocytopenia can be effective 
in preventing the invasive practice. The 
present study reviewed a case of 
thrombocytopenia in a patient who was 
treated with Triamterene-H. 
The patient was a 58-year-old woman 
diagnosed with type 2 diabetes mellitus (DM) 
since about 10 years ago and hypertension 
since 5 years ago. The patient was referred to 
the diabetes clinic of Arak University of 
Medical Sciences, Arak, Iran for her periodic 
diabetes care. DM and hypertension were 
controlled [Fasting blood sugar (FBS): 110, 
Hemoglobin A1C (HbA1C): 6.5, blood 
pressure (BP): 135/75 mm Hg], however 
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thrombocytopenia was observed in the 
patient's tests. She had been treated with 
metformin 500 mg, Atenolol 50 mg, and 
Lisinopril 5 mg daily. Due to the 
uncontrolled hypertension, Triamterene-H 
was added to the patient's medications more 
than one year ago. The patient presented a 
history of thrombocytopenia in several recent 
laboratory tests and was very worried about 
this. In the tests taken from the patient in the 
last few months, platelet decreased to 
92000/μl, 64000/μl, 54000/μl, and 46000/μl 
in 4 recent periodic tests. There was no family 
history of thrombocytopenia. There was no 
history of insect bites, recent travel, and 
allergies. There was no evidence of abnormal 
hemorrhage or skin lesions including Petechi 
and Purpura. The medical history and clinical 
examination were normal.  Liver and kidney 
function tests were normal. There was no 
abnormality in the patient's initial coagulation 
tests. The patient referred to a hematologist 
before referring to out diabetes clinic. 
Therefore, the hematologist recommended 
bone marrow aspiration and the patient did 
not want to give the test. Unfortunately, it 
was impossible to know the precise 
molecular mechanism of thrombocytopenia 
in this case because the patient refused to 
perform diagnostic tests prescribed 
(including bone marrow aspiration) by the 
hematologist. Due to the patient's past 
medical history, the physician of the 
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due to drug complications, and thus he 
advised discontinuation of the Triamterene-
H use and repeating the complete blood 
count (CBC) and differential (diff) tests a 
few weeks later. After about a month, the 
patient referred to the diabetes clinic. The 
platelet count increased to 132000/μl. 
Unfortunately, the patient did not refer for 
further follow-up. 
One of the reasons for thrombocytopenia 
is the destruction of platelets by drug-
induced antibody. Several drugs can cause 
antiplatelet antibodies and drug-induced 
thrombocytopenia. Among anti-hypertensive 
drugs, diuretics include acetazolamide, 
furosemide, hydrochlorothiazide, and 
Triamterene-H can produce antiplatelet 
antibodies and cause drug-induced 
thrombocytopenia.1 The reason for this  
issue is possible mechanisms approved.1 
Classic drug-induced immune mediated 
thrombocytopenia is caused by unusual 
antibodies that bind to complexes of drug  
(or drug metabolite) bound to platelet 
glycoproteins such as glycoprotein Ib-IX, 
glycoprotein IIb-IIIa, and platelet-endothelial 
cell adhesion molecule-1.1-3 Several systematic 
reviews of drug-induced thrombocytopenia 
have been carried out to strengthen the clinical 
evidence about this issue.3-5  
Paying attention to the side effects of 
drugs and patient medical history can help 
clinicians to diagnose adverse effects of 
drugs. Allocating enough time to get a 
detailed pharmacological and medical 
history of the patient is a guide in correct 
diagnosis and sometimes eliminates the need 
for expensive and invasive tests.  
In the present study, we reviewed a case 
of thrombocytopenia which was related to 
Triamterene-H, and the platelet count 
returned to the normal range in periodic 
laboratory tests after discontinuation of the 
drug. Therefore, clinicians should be aware 
of this potential adverse reaction and should 
be alert to medication thought to be the cause 
of thrombocytopenia. 
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